[Federal Register Volume 71, Number 63 (Monday, April 3, 2006)]
[Notices]
[Pages 16582-16583]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E6-4760]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Joint Meeting of the Dental Products Panel of the Medical Devices 
Advisory Committee of the Center for Devices and Radiological Health 
and the Peripheral and Central Nervous System Drugs Advisory Committee 
of the Center for Drug Evaluation and Research; Notice of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). The meeting will 
be open to the public.

[[Page 16583]]

    Names of Committees: The Dental Products Panel of the Medical 
Devices Advisory Committee of the Center for Devices and Radiological 
Health (CDRH) and the Peripheral and Central Nervous System Drugs 
Advisory Committee of the Center for Drug Evaluation and Research 
(CDER). This will be a joint meeting of the two committees.
    General Function of the Joint Committee: To provide advice and 
recommendations to the agency on FDA's regulatory issues.
    Date and Time: The meeting will be held on September 6 and 7, 2006, 
from 8 a.m. to 5 p.m.
    Location: Holiday Inn, Walker/Whetstone Rm., Two Montgomery Village 
Ave., Gaithersburg, MD.
    Contact Person: Michael E. Adjodha, Center for Devices and 
Radiological Health (HFZ-480), Food and Drug Administration, 9200 
Corporate Blvd., Rockville, MD 20850, 301-827-5283, ext. 123, e-mail: 
[email protected] or FDA Advisory Committee Information Line, 
1-800-741-8138 (301-443-0572) in the Washington, DC area), code 
3014512518. Please call the Information Line for up-to-date information 
on this meeting.
    Agenda: This joint committee will review and discuss peer-reviewed 
scientific literature on dental amalgam devices. Dental amalgam, also 
called ``encapsulated amalgam,'' consists of dental mercury and amalgam 
alloys. This joint committee will review and discuss peer-reviewed 
scientific literature on dental amalgam and its potential mercury 
toxicity, specifically as it relates to neurotoxic effects. Certain 
consumer groups have raised concerns about the effects of using mercury 
as a component of dental restorative materials; therefore, we are 
combining the expertise of the Dental Products Panel of the Medical 
Device Advisory Committee with the neurology expertise of the 
Peripheral and Central Nervous System Drugs Advisory Committee.
    Procedure: Interested persons may present data, information, or 
views, orally or in writing, on issues pending before the committee. 
Written submissions may be made to the contact person by August 23, 
2006. On September 6 and 7, 2006, oral presentations from the public 
will be scheduled at the beginning of committee deliberations and near 
the end of the deliberations. Time allotted for each presentation may 
be limited. Those desiring to make formal oral presentations should 
submit written notification to the contact person by August 23, 2006, 
and include the names and addresses of proposed participants, and an 
indication of the approximate time requested to make their 
presentation.
    Persons attending FDA's advisory committee meetings are advised 
that we are not responsible for providing access to electrical outlets.
    FDA welcomes the attendance of the public at its advisory committee 
meetings and will make every effort to accommodate persons with 
physical disabilities or special needs. If you require special 
accommodations due to a disability, please contact Ann Marie Williams, 
Conference Management Staff, 240-276-0450 ext. 113, at least 7 days in 
advance of the meeting.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: March 22, 2006.
Scott Gottlieb,
Deputy Commissioner for Policy.
[FR Doc. E6-4760 Filed 3-31-06; 8:45 am]
BILLING CODE 4160-01-S